India's Sun Pharma plans $1 billion local debt sale for loan takeout, sources say
- Sun Pharma to raise 100 billion rupees ($1.04 billion) in domestic debt, replacing a bridge loan for its major Organon acquisition
Subscribing is the best way to get our best stories immediately.